Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma

@article{Abrams2015TimingOS,
  title={Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma},
  author={Daniela Alexandru Abrams and Joseph A. Hanson and J Martin Brown and Frank P. K. Hsu and Daniela Annenelie Bota},
  journal={Journal of Clinical Neuroscience},
  year={2015},
  volume={22},
  pages={35-39}
}
Malignant gliomas continue to have a dismal prognosis despite all available treatments and advances made in understanding molecular mechanisms and signaling pathways. Conventional treatments, such as surgery, chemotherapy and radiation, have been used with limited success. Bevacizumab is a recently described molecule, which inhibits endothelial proliferation and prevents formation of new blood vessels in tumor. However, this treatment confers increased hemorrhage risk and impairs wound healing… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Similar Papers

Loading similar papers…